Adaptive Biotechnologies Management to Meet With BTIG

TipRanks12:50 ET

CAR T-cell Therapy Strategic Business Research Report 2024-2030: Allogeneic `Off-the-Shelf` CAR T-Cell Therapies Generate New Opportunities in Manufacturing - ResearchAndMarkets.com

BusinesswireDec 4 08:47 ET

Express News | Adaptive Biotechnologies Announces Over 65 Abstracts Featuring Clonoseq® Mrd Testing Across a Range of Blood Cancers to Be Presented at the 66TH Ash Annual Meeting

ReutersDec 3 07:30 ET

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring ClonoSEQ MRD Testing Across a Range of Blood Cancers to Be Presented at the 66th ASH Annual Meeting

GlobeNewswireDec 3 07:30 ET

Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?

BenzingaNov 26 22:37 ET

Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7

Moomoo NewsNov 19 03:36 ET · Ratings